COVID-19 in pregnancy & toddler brain development
Part of Mental health clinical trials.
This study looks at how COVID-19 infection during pregnancy might affect a toddler's brain development. Researchers will compare children who were exposed to the virus before birth with those who were not.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 2 years 9 months and 5 years old (33 to 60 months).
- Your child could have been exposed to COVID-19 during pregnancy, or not exposed (this study includes both groups).
- You (the parent) must give permission for your child to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares how babies born very early (before 34 weeks) during the COVID-19 pandemic developed compared to babies born early before the pandemic. Researchers want to understand if the pandemic affected how these vulnerable infants grew and developed.
This study follows pregnant women and their babies to learn more about COVID-19 and how it affects them. By taking part, you help researchers understand the virus and improve care for mothers and children.
This study does brain imaging (brain scans) in babies to better understand early brain development and how factors like family history and COVID-19 might relate to development. It may help researchers learn which babies could need extra support later.
This study follows children to compare development in kids exposed to Zika before birth versus similar children not exposed. The goal is to understand what effects Zika exposure may have on early brain development and long-term outcomes.
This study follows pregnant women with a viral infection (like COVID-19, HIV, or hepatitis) and their children to learn how the infection affects both. It helps doctors better understand and care for families during and after pregnancy.
This study looks at how newborns’ bodies are affected by COVID-19 around birth and whether a breathing support treatment (inhaled nitric oxide) changes outcomes. It also compares COVID-exposed babies and a similar group of babies without COVID who are not receiving the breathing treatment.
Hear when a new SARS CoV-2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.